Loading…
Akso Health Group is projected to rise to $1.95 by 2027, a +25% move from its current price of $1.56. AHG is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.49 | $1.56 | $1.64 | +0.05% |
| May 30 | $1.46 | $1.56 | $1.67 | +0.09% |
| May 31 | $1.44 | $1.56 | $1.69 | +0.14% |
| Jun 1 | $1.42 | $1.56 | $1.72 | +0.18% |
| Jun 2 | $1.41 | $1.56 | $1.74 | +0.23% |
| Jun 3 | $1.39 | $1.56 | $1.76 | +0.27% |
| Jun 4 | $1.38 | $1.57 | $1.77 | +0.32% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.38 | $1.57 | $1.77 | +0.32% |
| Week 2 | $1.32 | $1.57 | $1.87 | +0.64% |
| Week 3 | $1.27 | $1.58 | $1.95 | +0.97% |
| Week 4 | $1.23 | $1.58 | $2.03 | +1.29% |
| Week 5 | $1.20 | $1.59 | $2.09 | +1.61% |
| Week 6 | $1.17 | $1.59 | $2.16 | +1.94% |
| Week 7 | $1.15 | $1.60 | $2.22 | +2.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Akso Health Group operates a social e-commerce mobile platform in the People’s Republic of China. It runs Xiaobai Maimai App, a social e-commerce platform that offers a wide range of products, including food and beverage, wine, cosmetics, fashion and apparel, entertainment products, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices such as defibrillators and anesthesia laryngoscopes, and provides health treatment, consultancy support, marketing promotion services, technological promotion services, and import and export services.
Akso Health Group was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. It was founded in 2014 and is headquartered in Qingdao, China. The company operates within the Healthcare sector of its described market and combines e-commerce with healthcare-related product offerings and services.
AHG is currently priced at $1.53 per share, with a market capitalization of $1.31B and a market rank of 2325. The stock trades within a near-term technical framework that shows a flattering but cautious setup: it sits near a support level of $1.51 and faces resistance at $2.45. The thirty-day price range spans from $1.11 to $2.11, with an RSI of 30.0, a 50-day simple moving average of $2.15, and a 200-day simple moving average of $1.71.
The stock’s price volatility is elevated, at 90% annualized.
Looking at the year-by-year forecast, the model indicates a flat to modestly rising near-term path in 2026 (min $1.28, avg $1.53, max $2.32) with a neutral sentiment and ROI of 0. From 2027 onward, the outlook turns bullish, with the avg price rising to $2.04 in 2027 (ROI 33.4) and continuing to lift through successive years, culminating in a long-run bullish trajectory toward 2050 with a projected avg price of $17.35 and an ROI of 1034.1.
A major floor 37.2% below — a decisive break under it would weaken the trend.
The nearest floor, 3.2% below — buyers have tended to step in here.
The nearest ceiling, 49.4% above — a clean break opens room to run.
A major ceiling 67.9% above — clearing it would confirm fresh momentum.
Key AHG support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AHG market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.56 | Buy | $1.59 | Sell |
| MA 10 | $1.69 | Sell | $1.68 | Sell |
| MA 20 | $1.90 | Sell | $1.83 | Sell |
| MA 50 | $2.12 | Sell | $1.93 | Sell |
| MA 100 | $1.81 | Sell | $1.86 | Sell |
| MA 200 | $1.71 | Sell | $1.73 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 34.28 | Neutral |
| Stoch RSI (14) | 21.51 | Neutral |
| CCI (20) | -97.93 | Neutral |
| Williams %R (14) | -91.74 | Info |
| MACD (12,26,9) | -0.04 | Sell |
| ROC (12) | -21.21 | Sell |
| Bollinger %B (20,2) | 0.16 | Neutral |
| Stochastic %K (14) | 8.26 | Buy |
| TRIX (15) | -0.79 | Sell |
| Awesome (5,34) | -0.45 | Sell |
| Ultimate (7,14,28) | 28.28 | Buy |
| Momentum (10) | -0.56 | Sell |
| Aroon Osc (25) | -68.00 | Sell |
| Hull MA (9) | 1.50 | Buy |
| ADX (14) | 21.05 | Sell |
| ATR (14) | 0.08 | Info |
The 30-day technical picture is NEUTRAL. The RSI14 at 30 suggests modest near-term downside pressure but not an immediate pullback. The stock remains between a near-term support of $1.51 and a resistance of $2.45, with the 30-day range between $1.11 and $2.11.
The moving-average backdrop shows the SMA50 at $2.15 and the SMA200 at $1.71, indicating the short-term momentum is mixed and sensitive to price tests around the support and resistance levels. Given the current setup, traders might watch for a sustained move above the $2.45 resistance for a potential push toward the higher end of the range, or a break below $1.51 for renewed consolidation.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.28 | $1.56 | $2.30 | 0% | Neutral | |
| $1.44 | $1.95 | $2.86 | +25% | Bullish | |
| $1.93 | $2.75 | $4.25 | +76% | Bullish | |
| $2.02 | $3.02 | $4.87 | +93% | Bullish | |
| $2.23 | $3.46 | $5.79 | +122% | Bullish | |
| $2.14 | $3.45 | $5.95 | +121% | Bullish | |
| $1.81 | $3.01 | $5.35 | +93% | Bullish | |
| $2.16 | $3.72 | $6.77 | +138% | Bullish | |
| $2.38 | $4.23 | $7.88 | +171% | Bullish | |
| $2.67 | $4.90 | $9.33 | +214% | Bullish | |
| $2.64 | $5.63 | $11.70 | +261% | Bullish | |
| $6.51 | $14.46 | $33.27 | +827% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.28 | $1.56 | $1.84 | +0.00% |
| June 2026 | $1.34 | $1.60 | $1.97 | +2.27% |
| July 2026 | $1.34 | $1.63 | $2.05 | +1.94% |
| August 2026 | $1.28 | $1.56 | $2.00 | -3.91% |
| September 2026 | $1.30 | $1.61 | $2.09 | +2.76% |
| October 2026 | $1.40 | $1.75 | $2.30 | +8.97% |
| November 2026 | $1.40 | $1.76 | $2.35 | +0.74% |
| December 2026 | $1.35 | $1.71 | $2.30 | -3.06% |
Click any year to see its month-by-month AHG forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect AHG to range from $1.28 to $2.30 through 2026. The $1.56 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The AHG price prediction for 2027 points to an average of $1.95 (low $1.44, high $2.86) — a potential gain of +25% on today's $1.56. Momentum favours further upside here.
In 2028, AHG is projected to trade between $1.93 and $4.25, averaging $2.75 — a potential gain of +76% from today's $1.56. That is up +41% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Akso Health Group's 2029 outlook centres on $3.02, within a $2.02 to $4.87 range. That is up +10% on the projected 2028 average. That marks a +93% change versus current levels. Momentum favours further upside here.
By 2030, AHG could reach as high as $5.79, with a base case around $3.46 and support toward $2.23 — roughly +122% from $1.56. Buyers look set to stay in control over this stretch.
Expect AHG to range from $2.14 to $5.95 through 2031. The $3.45 average target implies a +121% move from current prices. That is 0% versus the projected 2030 average. Momentum favours further upside here.
The AHG price prediction for 2032 points to an average of $3.01 (low $1.81, high $5.35) — a potential gain of +93% on today's $1.56. Buyers look set to stay in control over this stretch.
In 2033, AHG is projected to trade between $2.16 and $6.77, averaging $3.72 — a potential gain of +138% from today's $1.56. That is up +23% on the projected 2032 average. Momentum favours further upside here.
Akso Health Group's 2034 outlook centres on $4.23, within a $2.38 to $7.88 range. That is up +14% on the projected 2033 average. That marks a +171% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, AHG could reach as high as $9.33, with a base case around $4.90 and support toward $2.67 — roughly +214% from $1.56. Momentum favours further upside here.
Expect AHG to range from $2.64 to $11.70 through 2040. The $5.63 average target implies a +261% move from current prices. That is up +15% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The AHG price prediction for 2050 points to an average of $14.46 (low $6.51, high $33.27) — a potential gain of +827% on today's $1.56. Momentum favours further upside here.
Investing $1,000 in AHG today (≈ 641.025641 AHG) could be worth
$9,271.43
+$8,271.43 (+827%) by 2050 · US Dollar
Based on the average projected AHG price of $14.46 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AHGwould be worth at today's price.
$1,000 invested in AHG on May 27, 2025 (≈ 520.562206 AHG) would be worth
$812.08
-$187.92 (-18.8%) today · 0.81× · US Dollar
Based on a AHG entry price of $1.92 vs. today's $1.56.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.6 | $975 | -2.5% |
| 1 month ago | $2.31 | $675.32 | -32.5% |
| 3 months ago | $1.4 | $1,114.29 | +11.4% |
| 6 months ago | $1.49 | $1,046.98 | +4.7% |
| 1 year ago | $1.92 | $812.08 | -18.8% |
| All time (5.0y) ago | $1.47 | $1,061.22 | +6.1% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AHG forecast.
Our base-case forecast reaches $3.10 around 2030.
Implied market cap at $3.10: $2.65B
The multi-year forecast paints a clear bullish arc after a flat start in 2026. The 2027 average price is $2.04 with a 33.4% ROI, followed by a steep ascent to a 2028 average of $2.92 and 90.9% ROI, and a 2029 average of $3.23 with 111.1% ROI. By 2030 the average is projected at $3.73 with 144% ROI, and by 2031 at $3.70 with 141.8% ROI.
2032 sees $3.28 (114.1%), 2033 $4.17 (172.8%), 2034 $4.81 (214.2%), and 2035 $5.62 (267.1%).
The long-range forecast continues to show strength, with 2040’s expected average of $6.51 and 325.2% ROI, and a dramatic rise by 2050 to an average of $17.35 with a 1034.1% ROI. These figures illustrate a sustained bullish trajectory across the horizon, albeit against a backdrop of high volatility (annualized volatility of 90%). Investors should balance the strong upside potential against the inherent uncertainty and the near-term neutral positioning seen in 2026.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $3.73 with a minimum of $2.37 and a maximum of $6.33, and a projected ROI of 144. The sentiment for 2030 is bullish.
The year-by-year forecast turns bullish from 2027 onward, with increasingly higher averages and ROIs (e.g., 2027 avg $2.04, ROI 33.4; 2028 avg $2.92, ROI 90.9; 2050 avg $17.35, ROI 1034.1). However, these are estimates and not guarantees, and the asset shows higher volatility (90%).
Yes. The forecast shows higher-price milestones including a 2029 max of $5.28 and a 2033 max of $7.72, with even higher levels as the horizon extends (e.g., 2040 max $13.75 and 2050 max $39.91).
AHG’s current price is $1.53 and its market capitalization is $1.31B. Its rank is 2325.
The near-term setup is neutral with an RSI of 30 and a stock price range between $1.11 and $2.11 over the last 30 days. The stock exhibits high volatility at 90%, which implies substantial price swings and risk alongside potential upside.
Akso Health Group Community Discussion
0Share your Akso Health Group price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.